Nanotechnology
Oncotelic and Sapu Bioscience Define Sub-15 nm Nanoparticles as New Frontier in Drug Delivery
Oncotelic Therapeutics and Sapu Bioscience have published a landmark review establishing sub-15 nm nanoparticles as a breakthrough drug delivery platform capable of overcoming limitations of current therapies through enhanced tissue penetration and reduced toxicity.
Oncotelic's Nanomedicine Platform Advances Cancer Treatment Through Enhanced Drug Delivery
Oncotelic Therapeutics' Deciparticle platform represents a significant advancement in nanomedicine that improves drug bioavailability and therapeutic effectiveness in oncology treatments.
Nanomedicine Breakthroughs Transform Cancer Drug Delivery and Bioavailability
Recent advancements in nanomedicine technology are revolutionizing oncology treatment by improving drug delivery systems, enhancing bioavailability, and potentially transforming underperforming cancer drugs into effective therapies through platforms like Oncotelic Therapeutics' Deciparticle.
Oncotelic's 20nm Nanoparticle Technology Enters Human Trials for Enhanced Breast Cancer Treatment
Oncotelic Therapeutics has begun human trials for its 20nm nanoparticle formulation of Everolimus, representing a significant advancement in cancer drug delivery that could dramatically improve tumor targeting and treatment efficacy.
Nanoparticle Breakthrough Offers New Hope for Alcohol-Related Liver Disease Treatment
Researchers have developed innovative nanoparticles that could combat scarring and inflammation in alcohol-related liver disease, potentially creating a treatment template applicable to other organs.
Sapu Nano Receives Australian Ethics Approval for Breast Cancer Drug Trial
Sapu Nano's Sapu003, an injectable form of Everolimus using proprietary nanoparticle technology, has received HREC approval for human clinical trials in Australia, potentially offering more effective breast cancer treatment through improved drug delivery.
Oncotelic Therapeutics Advances Cancer Research with AI and Nanomedicine Pipeline
Oncotelic Therapeutics is leveraging artificial intelligence and nanomedicine to develop innovative treatments for aggressive cancers and rare pediatric diseases, backed by a substantial intellectual property portfolio.
Oncotelic Therapeutics Advances Cancer and Rare Disease Treatments Through AI and Nanomedicine Innovations
Oncotelic Therapeutics is leveraging artificial intelligence, nanomedicine, and a robust intellectual property portfolio to develop transformative treatments for difficult cancers and rare pediatric diseases, positioning itself among leading innovators in biotechnology.
Alfa Chemistry Expands Diamond Materials Portfolio for Precision Manufacturing Applications
Alfa Chemistry's launch of advanced diamond materials addresses critical needs in semiconductor production, optical engineering, and biomedical research by enabling sub-micron surface control and precision polishing.
Lorati's Nano-Emulsion Offers New Hope for Stroke Recovery
Lorati Co., Ltd. introduces a natural, mineral-based nano-emulsion therapy that promises a non-invasive solution for full recovery from both hemorrhagic and ischemic strokes, marking a significant advancement in stroke treatment.
Creative Biolabs Advances Liposome Technology for Enhanced Drug Delivery
Creative Biolabs is pioneering liposome technology to improve drug delivery systems, offering innovative solutions for pharmaceutical industries and beyond.
Breakthrough in Spin Photonics Offers New Avenues for Optical Innovation
Researchers in China have developed a folded-path metasurface platform that overcomes bandwidth constraints in spin photonics, enabling independent dispersion and phase control of two opposite spin states for the first time.
Fidget Spinner Transforms into Rapid Bacterial Detection Device
Researchers have developed a novel diagnostic tool using a fidget spinner with nanoplasmonic technology to detect bacterial species quickly and accurately. This innovative device could revolutionize point-of-care diagnostics, especially in resource-limited settings.